Jerome D. Jabbour
2020
In 2020, Jerome D. Jabbour earned a total compensation of $2.9M as Chief Executive Officer at Matinas BioPharma Holdings, a 121% increase compared to previous year.
Compensation breakdown
| Bonus | $250,000 |
|---|---|
| Option Awards | $2,180,085 |
| Salary | $500,000 |
| Total | $2,930,085 |
Jabbour received $2.2M in option awards, accounting for 74% of the total pay in 2020.
Jabbour also received $250K in bonus and $500K in salary.
Rankings
In 2020, Jerome D. Jabbour's compensation ranked 3,949th out of 13,090 executives tracked by ExecPay. In other words, Jabbour earned more than 69.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,949 out of 13,090 | 70th |
Division Manufacturing | 1,578 out of 5,620 | 72nd |
Major group Chemicals And Allied Products | 597 out of 2,253 | 74th |
Industry group Drugs | 515 out of 1,953 | 74th |
Industry Pharmaceutical Preparations | 389 out of 1,458 | 73rd |
Source: SEC filing on September 22, 2022.
Jabbour's colleagues
We found two more compensation records of executives who worked with Jerome D. Jabbour at Matinas BioPharma Holdings in 2020.
News
Matinas BioPharma Holdings CEO Jerome Jabbour's 2022 pay falls 55% to $1.7M
September 19, 2023
Matinas BioPharma Holdings CEO Jerome Jabbour's 2021 pay jumps 26% to $3.7M
September 22, 2022
Matinas BioPharma Holdings CEO Jerome Jabbour's 2019 pay rises 6% to $1.3M
October 1, 2020
Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
September 24, 2019